| Tue, Feb 9, 2010 | | | Biotech ETFs Immune To Broad Selling Investor's Business Daily (Tue 9:34AM)
| | | Alkermes Retains Neutral Rec Zacks.com (Tue 7:07AM)
| | Sat, Feb 6, 2010 | | | AMYLIN PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Sat, Feb 6)
| | Fri, Feb 5, 2010 | | | Alkermes Testing its Version of Popular Schizophrenia Drug at TheStreet.com (Fri, Feb 5)
| | | Alkermes Testing Schizophrenia Drug at TheStreet.com (Fri, Feb 5)
| | Wed, Feb 3, 2010 | | | Novo Nordisk Has High Hopes for Diabetes Blockbuster at Seeking Alpha (Wed, Feb 3)
| | | The Shaky State Of California Biopharma at CNBC (Wed, Feb 3)
| | | Eli Lilly and the Depression-Diabetes Circle at Minyanville.com (Wed, Feb 3)
| | | UPDATE - Novo Nordisk ups outlook, Q4 EBIT beats consensus at Reuters (Wed, Feb 3)
| | | 2-Star Stocks Poised to Plunge: MannKind? at Motley Fool (Wed, Feb 3)
| | | Weekly Street Sentiment: Mostly Cloudy with a Chance of Sunshine at Seeking Alpha (Wed, Feb 3)
| | Tue, Feb 2, 2010 | | | Monday Options Recap at Seeking Alpha (Tue, Feb 2)
| | | PREVIEW-Novo Nordisk Q4 seen down but 2010 rosier at Reuters (Tue, Feb 2)
| | Mon, Feb 1, 2010 | | | Novo Nordisk Awaits China Approval of Diabetes Treatment at Seeking Alpha (Mon, Feb 1)
| | Sat, Jan 30, 2010 | | | [$$] 13D Filings at Barrons.com (Sat, Jan 30)
| | | Wake Up! You Still Have to Pay Attention at Motley Fool (Sat, Jan 30)
| | | Icahn Back to Batter Biogen at Motley Fool (Sat, Jan 30)
| | | AstraZeneca, Eli Lilly Foreboding for Sector at Minyanville.com (Sat, Jan 30)
| | | Amylin Misses Estimates Zacks.com (Sat, Jan 30)
| | Fri, Jan 29, 2010 | | | The Next Amgen? Not Yet. at Motley Fool (Fri, Jan 29)
| | Older Headlines | |
| |
|